or
forgot password

    • cancer clinical trials in peoria, IL

    • Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    OSF Saint Francis Medical Center

    Trial Locations
    OSF Saint Francis Medical Center
    Illinois CancerCare-Peoria
    Lung Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    OSF Saint Francis Medical Center

    Trial Locations
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Saint Jude Midwest Affiliate
    Peoria, Illinois 61637
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    CCOP - Illinois Oncology Research Association

    Trial Locations
    CCOP - Illinois Oncology Research Association
    Methodist Medical Center of Illinois
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Proctor Hospital
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Methodist Medical Center of Illinois

    Trial Locations
    Methodist Medical Center of Illinois
    Proctor Hospital
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    OSF Saint Francis Medical Center Radiation Oncology Service at the Central Illinois Comprehensive CC
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Methodist Medical Center of Illinois

    Trial Locations
    Methodist Medical Center of Illinois
    Proctor Hospital
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    OSF Saint Francis Medical Center Radiation Oncology Service at the Central Illinois Comprehensive CC
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Oncology Hematology Associates of Central Illinois, PC - Peoria

    Trial Locations
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Proctor Hospital
    Lymphoma
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    OSF Saint Francis Medical Center

    Trial Locations
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
    CCOP - Illinois Oncology Research Association

    Trial Locations
    CCOP - Illinois Oncology Research Association
    Methodist Medical Center of Illinois
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Proctor Hospital
    Lymphoma
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    OSF Saint Francis Medical Center

    Trial Locations
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    Oncology Hematology Associates of Central Illinois, PC - Peoria

    Trial Locations
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Proctor Hospital
    Lung Cancer
    S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    CCOP - Illinois Oncology Research Association

    Trial Locations
    CCOP - Illinois Oncology Research Association
    Methodist Medical Center of Illinois
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Proctor Hospital
    Breast Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Methodist Medical Center of Illinois

    Trial Locations
    Methodist Medical Center of Illinois
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Proctor Hospital
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific